- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 2, 2024 | 70.46M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 94.82M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 93.39M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $146K |
| Capex | Q1 2024 · Mar 31, 2023 | $210K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$10.69M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$16.98M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $10.91M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $12.47M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $10.8M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $24.9M |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $15.01M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $32.77M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $18.58M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $14.01M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $24.53M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $28.42M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $68.58M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $81.96M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $18.95M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $35.32M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $32.24M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $49.74M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $52.65M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $65.27M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $56.78M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $78.16M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.07 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.16 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.07 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.16 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $10.06M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $14.11M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $2.19M |
| Rd Expense restated | Q1 2024 · Mar 31, 2023 | $2.93M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$6.76M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$15.37M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$10.25M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$15.06M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $2M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $1.98M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $5.05M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $6.7M |
| Revenue | Q1 2024 · Mar 31, 2024 | $7.05M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $8.68M |